Myelodysplastic syndrome: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 23: Line 23:


==[[Myelodysplastic syndrome pathophysiology|Pathophysiology]]==
==[[Myelodysplastic syndrome pathophysiology|Pathophysiology]]==
==[[Myelodysplastic syndrome causes|Causes]]==
==[[Myelodysplastic syndrome differential diagnosis|Differentiating Myelodysplastic syndrome from other Diseases]]==


==[[Myelodysplastic syndrome epidemiology and demographics|Epidemiology & Demographics]]==
==[[Myelodysplastic syndrome epidemiology and demographics|Epidemiology & Demographics]]==
Line 29: Line 33:


==[[Myelodysplastic syndrome screening|Screening]]==
==[[Myelodysplastic syndrome screening|Screening]]==
==[[Myelodysplastic syndrome causes|Causes]]==
==[[Myelodysplastic syndrome differential diagnosis|Differentiating Myelodysplastic syndrome from other Diseases]]==


==[[Myelodysplastic syndrome natural history|Natural History, Complications & Prognosis]]==
==[[Myelodysplastic syndrome natural history|Natural History, Complications & Prognosis]]==

Revision as of 07:55, 31 August 2012

For patient information, click here

Myelodysplastic syndrome
ICD-10 D46
ICD-9 238.7
ICD-O: 9980/0-9989/3
DiseasesDB 8604
MeSH D009190

Myelodysplastic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelodysplastic syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myelodysplastic syndrome On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myelodysplastic syndrome

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myelodysplastic syndrome

CDC on Myelodysplastic syndrome

Myelodysplastic syndrome in the news

Blogs on Myelodysplastic syndrome

Directions to Hospitals Treating Myelodysplastic syndrome

Risk calculators and risk factors for Myelodysplastic syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myelodysplastic syndrome from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

History & Symptoms | Physical Examination | Staging | Lab Tests | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention

Related chapters

Additional Readings

  • Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189. PMID 6952920.
  • Block M, Jacobson LO, Bethard WF. Preleukemic acute human leukemia. JAMA 1953;152:1018-28. PMID 13052490.
  • Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49. PMID 10577857.
  • Foucar, K Bone Marrow Pathology, 2nd Edition, ASCP Press. c 2001
  • Greenberg, Peter L. (editor) "Myelodysplastic Syndromes: Clinical and Biological Advances" Cambridge University Press, New York 2006 ISBN 978-0521496681 ISBN 0521496683
  • Steensma DP, Gibbons RJ, Higgs DR. "Acquired alpha-thalassemia in association with myelodysplastic syndrome and other hematologic malignancies." Blood 2005;105:443-452. PMID 15358626.
  • List A, Dewald G, Bennett J, Giagnounidis A, Raza A, Feldman E, Powell B, Greenberg P, Thomas D, Store R, Reeder C, Wride K, Patin J, Schmidt M, Zeldis J, Knight R. "Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion." NEJM 2006;355(14):1456-1465. PMID 17021321.
  • Fenaux P, Mufti GJ, Lindberg EH, Santini V, Finelli C, Giagounidis A, Schoch R, Gatterman N, Sanz G, List A, Gore SD, Seymour JF, Bennett JM, Byrd J, Backstrum J, Zimmerman JF, McKenzie D, Beach CL, Silverman LR. "Efficacy of Azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised open-label phase III study." Lancet Oncology 2009;10(3):223-232. PMID 19230772.

Resources

Template:Hematology

Template:SIB ar:متلازمة خلل التنسج النقوي de:Myelodysplastisches Syndrom sv:Myelodysplastiskt syndrom


Template:WikiDoc Sources